Evaluation of postoperative clinical outcomes in Jehovah's Witness patients who receive prothrombin complex concentrate during cardiac surgery

ConclusionsIn JWs undergoing cardiac surgery who refuse alloBT, intraoperative use of 4PCC was not associated with a difference in Hgb change within 7 days postoperatively when adjusting for confounding variables. In the event of excessive blood loss, the utilization of 4PCC may provide a viable option in JW patients who undergo cardiac surgery where few options exist to mitigate blood loss.

Source: Journal of Cardiac Surgery - February 13, 2020 Category: Cardiovascular & Thoracic Surgery Authors: Jesse E. Harris, Sara Varnado, Elizabeth Herrera, Eric Salazar, Anthony C. Colavecchia Tags: ORIGINAL ARTICLE Source Type: research